INTERVIEWS

Dr. Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications discusses the APOLLO trial that is investigating MT-601, a multi-tumor-associated antigen (multiTAA)-specific T cell product targeting six antigens, for the treatment of patients with lymphoma who have failed or are ineligible to receive anti-CD19 CAR T cell treatment.

Returning guest, Dr. Andrew Cutler, Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and CEO of Florida Clinical Research Center, LLC discusses real-world data from the START study demonstrating favorable efficacy and adherence among people living with TD who used a 4-week titration kit to reach optimal dosing with AUSTEDO ® (deutetrabenazine).

David Longo, Co-Founder and CEO of Ordaōs, an AI-driven drug design company, discusses generative AI and how Ordaos is using AI to design novel and customized mini-proteins they refer to as miniPRO ™. They achieve this development through their Odaōs Design Engine which leverages continuous learning loops and proprietary data sets to translate human-defined product criteria into machine-designed mini-proteins which can be safer and more effective. David will discuss what HCPs need to know about AI, how it can benefit drug design and development, and how AI can help create better drugs, faster, at less cost, and lower risk, and what this means for them.

Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as well as regulatory decisions to inform healthcare’s most critical decisions, advance access to medications, and ultimately improve patient care.

Dr. David Rosmarin, Ph.D, is the Director of the Spirituality and Mental Health Program at McLean Hospital, associate professor of psychology in the Department of Psychiatry at Harvard Medical School, and founder of Center for Anxiety discusses his new book (Oct 2023) titled “Thriving With Anxiety.” He reframes anxiety and explains Anxiety is not a disease; it is a natural human experience that can help us thrive throughout life when we learn to harness it as a resource.

Jaideep Singh, Co-Founder and CEO of Ambee talks about his passion for the environment, helping people improve their lives, and the groundbreaking environmental data the company has uncovered and how they’re making it actionable with a tech service like Allegra Airways.

Dr. Purvi Parikh, a renowned allergist at NYU Langone Health discusses the launch of Allegra’s new, first-of-its-kind map app called Airways that guides users to their destinations with real-time cleaner routes (least amount of air pollution and pollen). It essentially identifies a cleaner air commuting route and the best routes to avoid, like the Waze traffic app, but for clean-route commuting.

Lora Sparkman, RN, BSN, MHA, VP, Partner, Clinical Solutions, Patient Safety and Quality at Relias and Nurse.com ambassador, discusses the current maternal mortality crisis and steps healthcare organizations can take to improve the quality of care.

Meredith Huetter, a stage lll colorectal cancer survivor, shares her personal story of learning she had CRC and how her treatment journey has gone thus far.

Dr. David Stein, PhD, CEO of Babson Diagnostics discusses how Babson is reimagining the blood testing process by only using only a pea-sized amount of blood collected from the finger. Babson’s BetterWay™ Blood Testing eco-system is unique because it brings medically accurate blood testing to the convenience of a retail pharmacy, empowering people to better take charge of their health.